Skip to main content

Animations

MJFF Publications

4341 - 4350 of 6230 Results
Title
Year
  • Year
  • 2018
  • 2020
  • 2022
  • 2019
  • 2016
  • 2019
  • 2018
  • 2017
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: The E3 Ubiquitin Ligases TRIM17 and TRIM41 Modulate α-Synuclein Expression by Regulating ZSCAN21
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2018.11.002
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Intramolecular Povarov Reactions for the Synthesis of Chromenopyridine Fused 2-Pyridone Polyheterocycles Binding to α-Synuclein and Amyloid-β Fibrils
    Journal Name: The Journal of Organic Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acs.joc.0c01699
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Effect of olfactory bulb pathology on olfactory function in normal aging
    Journal Name: Brain Pathology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/bpa.13075
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.jalz.2019.08.196
    Citation Count: 36
  • Summary Details
    OPEN
    Title: T2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson’s Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2016.00174
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.1814909116
    Citation Count: 98
  • Summary Details
    OPEN
    Title: Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.08.010
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's disease
    Journal Name: Toxicology and Applied Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.taap.2017.04.004
    Best OA location URL:
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2021.105409
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Demographic Influences on the Relationship Between Fatigue and Quality of Life in Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13360
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.